‘Undruggable’ Cancers Potentially Treatable By Targeting Growth Signals

Scientists discovered a compound that could slow down cancer growth in a number of different cancer cell lines. It involves targeting growth-related defects in a cell-signaling pathway called RAS/MAPK.